Jeremy Duffield

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Karen Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy Duffield:

Company Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. Chief Scientific Officer Stock Option (right to buy) 275,000 27 Feb 2025 Direct

Insider Reports Filed by Jeremy Duffield

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PRME Prime Medicine, Inc. 27 Feb 2025 1 $0 4 Chief Scientific Officer 03 Mar 2025, 20:15
PRME Prime Medicine, Inc. 21 Feb 2024 1 $0 4 Chief Scientific Officer 23 Feb 2024, 17:03
PRME Prime Medicine, Inc. 31 Mar 2023 1 $0 4 Chief Scientific Officer 04 Apr 2023, 20:23
PRME Prime Medicine, Inc. 19 Oct 2022 0 $0 3 Chief Scientific Officer 19 Oct 2022, 20:02